Prometheus Launches ProOnc Dx Cancer Diagnostics – Reuters
Filed in Mesothelioma News on Oct.15, 2009
Prometheus Launches ProOnc Dx Cancer Diagnostics Reuters ProOnc Mesothelioma Dx is a cutting-edge molecular diagnostic test that uses microRNA to differentiate malignant pleural mesothelioma from peripheral … Market Report — In Play () MSN Money all 7 news articles

Leave a Reply
You must be logged in to post a comment.